
MVA-member company, 2CureX, raises ambitions for launch according to CEO and founder, Ole Thastrup. Their first product, Inditreat, helps help cancer doctors choose the optimal medical treatments for bowel cancer patients, and later, other types of cancer patients. Read full article in Medwatch in Danish and English